<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="43638">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02025725</url>
  </required_header>
  <id_info>
    <org_study_id>METO-IN-003</org_study_id>
    <nct_id>NCT02025725</nct_id>
  </id_info>
  <brief_title>Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis</brief_title>
  <official_title>Phase 3 Study of Intranasal Metoclopramide in Women With Symptomatic Diabetic Gastroparesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Evoke Pharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Evoke Pharma</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is provide confirmation of the safety and efficacy of
      Metoclopramide Nasal Spray compared to placebo in reducing the symptoms of diabetic
      gastroparesis in adult women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diabetic women with clinical symptoms attributed to diabetic gastroparesis and documentation
      of delayed gastric emptying who meet the protocol-specified entry criteria will be
      randomized to Metoclopramide Nasal Spray 10 mg or placebo administered as a single
      intranasal spray four (4) times daily; 30 minutes before meals and at bedtime for a total of
      four (4) weeks.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Patient Reported Outcome (PRO) Symptom Diary</measure>
    <time_frame>Change from baseline in symptom score at Week 4</time_frame>
    <safety_issue>No</safety_issue>
    <description>Subjects will an interactive voice response system (IVRS) to record the severity of their gastroparesis symptoms on a daily basis until their last full day on study prior to their final visit</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Population Pharmacokinetics</measure>
    <time_frame>Study Day 7</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pharmacokinetic parameters derived from the plasma concentrations of metoclopramide collected; maximum plasma concentration (Cmax), time to Cmax (Tmax), elimination half-life (t1/2), areas under the concentration-time curve (AUC) to the final sample AUC(0-t)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Diabetic Gastroparesis</condition>
  <arm_group>
    <arm_group_label>10 mg Metoclopramide Nasal Spray</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Metoclopramide Nasal Spray 10 mg, 30 minutes before meals and at bedtime (QID) for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Nasal Spray</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo Nasal Spray 30 minutes before meals and at bedtime (QID) for 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metoclopramide Nasal Spray</intervention_name>
    <description>nasal spray formulation of metoclopramide</description>
    <arm_group_label>10 mg Metoclopramide Nasal Spray</arm_group_label>
    <other_name>EVK-001</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Nasal Spray</intervention_name>
    <description>nasal spray formulation with vehicle only</description>
    <arm_group_label>Placebo Nasal Spray</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non pregnant, non lactating female subjects between the ages of 18 and 75 years

          -  Willingness and ability to give written informed consent

          -  The ability to read, understand and speak English

          -  Prior diagnosis of Type 1 or Type 2 diabetes

          -  Diagnosis of diabetic gastroparesis with confirmation of delayed gastric emptying

          -  A mean daily gastroparesis symptom score of ≥1.4 and ≤3.5 prior to randomization

          -  Subjects of childbearing potential must agree to use contraception

          -  No clinically significant abnormal findings on the physical examination, medical
             history, or clinical laboratory results which, in the opinion of the Investigator,
             would interfere with intranasal dosing, jeopardize the safety of the subject or
             impact the validity of the study results

          -  Willingness to discontinue current treatment for diabetic gastroparesis and to avoid
             all proscribed (excluded) medications, as specified by the protocol, for the duration
             of the study

        Exclusion Criteria:

          -  Gastric bypass, gastric banding, gastric pacemaker, post surgical causes of
             gastroparesis and disorders known to be associated with abnormal gastrointestinal
             motility

          -  A history of allergic or adverse responses, including, but not limited to, acute
             dystonic reactions and tardive dyskinesia, to metoclopramide or any comparable or
             similar product

          -  A history of, or physical findings suggestive of, tardive dyskinesia

          -  A history of epilepsy or currently using and unwilling or unable stop other drugs
             known to be associated with extrapyramidal reactions at screening

          -  A history of allergy to any of the ingredients in the study drug formulation;
             metoclopramide, citric acid, sodium citrate, benzalkonium chloride,
             ethylenediaminetetraacetic acid (EDTA), or sorbitol

          -  A history of organ transplant, chronic pancreatitis, gross malabsorptive syndromes,
             celiac disease, active inflammatory bowel disease (IBD), or symptomatic irritable
             bowel syndrome (IBS)

          -  Malignancy (with the exception of treated squamous cell or basal cell carcinoma of
             the skin) currently present, initially diagnosed or recurring within five (5) years
             of screening

          -  A history of other clinically significant renal, hepatic, neurologic, hematologic,
             oncologic, pulmonary, psychiatric, cardiovascular or infectious disease, or any other
             condition which, in the opinion of the Investigator, would jeopardize the safety of
             the subject or impact the validity of the study results

          -  Renal dysfunction calculated as creatinine clearance (CrCl) &lt;40 mL/min at screening

          -  Hemoglobin A1c &gt;11.5% at screening

          -  Subjects who are trying to conceive, are pregnant, or are lactating

          -  Positive serum human chorionic gonadotropin (HCG) pregnancy test at screening or a
             positive HCG urine test on Day 0

          -  A history of alcohol or drug abuse within the year prior to the screening visit, or
             current known evidence of substance dependence or abuse

          -  Participation in a clinical (investigational) trial or receipt of a non FDA approved
             therapy within 30 days prior to the screening visit
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marilyn R. Carlson, DMD, MD</last_name>
    <role>Study Director</role>
    <affiliation>Evoke Pharma, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Birmingham Gasteroenterology Associates, P.C.</name>
      <address>
        <city>Birminham</city>
        <state>Alabama</state>
        <zip>35209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Ingle</last_name>
      <phone>205-271-8000</phone>
      <email>single@bgapc.com</email>
    </contact>
    <investigator>
      <last_name>John C Shallcross, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Digestive Specialists of the Southeast</name>
      <address>
        <city>Dothan</city>
        <state>Alabama</state>
        <zip>36305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Williams, NP</last_name>
      <phone>334-836-1055</phone>
      <email>cwilliams@dothangi.com</email>
    </contact>
    <contact_backup>
      <last_name>Dawn Barnes, MSN</last_name>
      <phone>334-836-3341</phone>
      <email>dbarnes@dothangi.com</email>
    </contact_backup>
    <investigator>
      <last_name>Samuel J Tarwater, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Research Associates</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin McCulley, CRC</last_name>
      <phone>256-536-6600</phone>
      <email>emcculley@cra-al.biz</email>
    </contact>
    <investigator>
      <last_name>Allen Goetsch, MD, CPI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arkansas Gastroenterology</name>
      <address>
        <city>Sherwood</city>
        <state>Arkansas</state>
        <zip>72120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenneth Voss</last_name>
      <phone>501-945-9300</phone>
      <email>kenneth@arkgi.net</email>
    </contact>
    <contact_backup>
      <last_name>Stephanie Hogue</last_name>
      <phone>501-945-9300</phone>
      <email>stephaniehogue@arkgi.net</email>
    </contact_backup>
    <investigator>
      <last_name>Gary Barton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Precision Research Institute, LLC</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jorge Hoyos, MD</last_name>
      <phone>619-501-0371</phone>
      <email>jorge@prisandiego.com</email>
    </contact>
    <investigator>
      <last_name>Taddese Desta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nature Coast Clinical Research</name>
      <address>
        <city>Inverness</city>
        <state>Florida</state>
        <zip>34452</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Gray, RN</last_name>
      <phone>352-341-2100</phone>
      <email>lgray@encoredocs.com</email>
    </contact>
    <investigator>
      <last_name>Paul Hellstern, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>International Research Associates, LLC</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33183</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annie Salvarrey</last_name>
      <phone>786-269-0628</phone>
      <email>asalvarrey@intrallc.com</email>
    </contact>
    <contact_backup>
      <last_name>Gustavo Canelon</last_name>
      <phone>305-670-8830</phone>
      <email>gcanelon@intrallc.com</email>
    </contact_backup>
    <investigator>
      <last_name>Cristian Breton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Research Institute</name>
      <address>
        <city>New Port Richey</city>
        <state>Florida</state>
        <zip>34653</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joleen Beninati, LPN</last_name>
      <phone>727-835-3262</phone>
    </contact>
    <investigator>
      <last_name>Israel Crespo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Medical Research</name>
      <address>
        <city>Port Orange</city>
        <state>Florida</state>
        <zip>32127</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadid Afghani</last_name>
      <phone>608-664-9000</phone>
      <email>nafghanie@amrcus.com</email>
    </contact>
    <contact_backup>
      <last_name>Sarah Ragsdale</last_name>
      <phone>608-664-9000</phone>
      <email>sragsdale@amrcus.com</email>
    </contact_backup>
    <investigator>
      <last_name>Ammar Hemaidan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Newton Medical Center</name>
      <address>
        <city>Conyers</city>
        <state>Georgia</state>
        <zip>30013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sunil Khetarpal</last_name>
      <phone>770-922-1778</phone>
      <email>khetarpal_sunil@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Kaushik Amin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gastrointestinal Specialists of Georgia, PC</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janet Plumley, LPN, CCRC</last_name>
      <phone>678-819-4237</phone>
      <email>jplumley@gigeorgia.com</email>
    </contact>
    <contact_backup>
      <last_name>Patricia Hernandez, NP</last_name>
      <phone>678-819-4272</phone>
      <email>phernandez@gigeorgia.com</email>
    </contact_backup>
    <investigator>
      <last_name>Aasim Sheikh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Professional Research Network of Kansas</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barb Loewen, RN</last_name>
      <phone>316-838-7700</phone>
      <email>bloewen@prnofkansas.com</email>
    </contact>
    <contact_backup>
      <last_name>Kim Talbot</last_name>
      <phone>316-838-7700</phone>
      <email>ktalbot@prnofkansas.com</email>
    </contact_backup>
    <investigator>
      <last_name>Dennis K Buth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Delta Research Partners, LLC</name>
      <address>
        <city>Monroe</city>
        <state>Louisiana</state>
        <zip>71201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa McCullars, RN</last_name>
      <phone>318-807-0819</phone>
      <email>mmccullars@gastromds.com</email>
    </contact>
    <investigator>
      <last_name>Bal Raj Bhandari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Digestive Health</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48098</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Baker, RN, BSN</last_name>
      <phone>248-267-8485</phone>
      <email>kbaker@troygastro.com</email>
    </contact>
    <investigator>
      <last_name>Richard Wille, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gastroenterology Associates of Western Michigan</name>
      <address>
        <city>Wyoming</city>
        <state>Michigan</state>
        <zip>49519</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeanne Host</last_name>
      <phone>616-452-5319</phone>
      <email>jhost@gastro-assoc-wm.com</email>
    </contact>
    <investigator>
      <last_name>Allen Coates, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gastrointestional Associates</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Darwin, RN</last_name>
      <phone>601-863-0395</phone>
      <email>donna.darwin@gastrodocs.net</email>
    </contact>
    <investigator>
      <last_name>Paul Milner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kansas City Gastroenterology &amp; Hepatology</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Vargas</last_name>
      <phone>816-361-0055</phone>
      <email>kvargas@kcresearchinstitute.com</email>
    </contact>
    <contact_backup>
      <last_name>Laurie Lynn</last_name>
      <phone>816-361-0055</phone>
      <email>llynn@kcresearchinstitute.com</email>
    </contact_backup>
    <investigator>
      <last_name>Bradley L. Freilich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Gastroenterology Group of South Jersey</name>
      <address>
        <city>Vineland</city>
        <state>New Jersey</state>
        <zip>08360</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Pagan</last_name>
      <phone>856-691-1400</phone>
      <email>mpagan3291@aol.com</email>
    </contact>
    <investigator>
      <last_name>Gary Matusow, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lovelace Scientific Resources, Inc.</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ericka Maldonado, CRC</last_name>
      <phone>505-348-9500</phone>
      <email>emaldonado@lrri.org</email>
    </contact>
    <investigator>
      <last_name>Michael McGuire, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Premier Medical Group of the Hudson, PC</name>
      <address>
        <city>Poughkeepsie</city>
        <state>New York</state>
        <zip>12601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alyson Cahill, MS</last_name>
      <phone>845-451-7262</phone>
      <email>acahill@premiermedicalhv.com</email>
    </contact>
    <investigator>
      <last_name>Peter M Varunok, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cumberland Research Associates</name>
      <address>
        <city>Fayetteville</city>
        <state>North Carolina</state>
        <zip>28304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loretta Joyce</last_name>
      <phone>910-484-8163</phone>
      <email>ljoyce@cumberlandresearchassociates.com</email>
    </contact>
    <investigator>
      <last_name>Valli Kodali, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LeBauer Research Associates</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27406</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Ward</last_name>
      <phone>336-323-3229</phone>
      <email>carol.ward@conehealth.com</email>
    </contact>
    <contact_backup>
      <last_name>Nancy Campbell</last_name>
      <phone>336-547-1739</phone>
      <email>nancy.campbell@cone.health.com</email>
    </contact_backup>
    <investigator>
      <last_name>Robert D Kaplan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Research Associates</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Center</last_name>
      <phone>919-781-2514</phone>
      <email>scenter@wakeresearch.com</email>
    </contact>
    <investigator>
      <last_name>Charles Barish, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Piedmont Medical Research</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy Dillard</last_name>
      <phone>336-714-2620</phone>
      <email>cdillard@pmg-research.com</email>
    </contact>
    <investigator>
      <last_name>Robert J Holmes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dayton Gastroenterology</name>
      <address>
        <city>Beavercreek</city>
        <state>Ohio</state>
        <zip>45440</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Kesler, BSN</last_name>
      <phone>937-320-5050</phone>
      <phone_ext>3031</phone_ext>
      <email>skesler@daytongastro.com</email>
    </contact>
    <investigator>
      <last_name>Larry W Weprin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NW Gastroenterology Clinic</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer B Rector</last_name>
      <phone>503-229-7180</phone>
      <email>jborruelr@nwgastro.net</email>
    </contact>
    <investigator>
      <last_name>William Bennetts, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Temple University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gastro One</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlotte Brooks</last_name>
      <phone>901-309-6036</phone>
      <email>cbrooks@gastro1.com</email>
    </contact>
    <investigator>
      <last_name>Ziad Younes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HCCA Clinical Research Solutions</name>
      <address>
        <city>Jackson</city>
        <state>Tennessee</state>
        <zip>37805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vickie Grigsby, RN</last_name>
      <phone>731-431-5027</phone>
      <email>vgrigsby@crssites.com</email>
    </contact>
    <investigator>
      <last_name>Bob Souder, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gastroenterology Associates</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Ladd, CRC</last_name>
      <phone>423-230-3154</phone>
      <email>kelly_ladd@gastrotn.com</email>
    </contact>
    <investigator>
      <last_name>Douglas Homoky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Quality Medical Research</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Stahl, CRC</last_name>
      <phone>615-835-4750</phone>
      <email>cstahl@qualitymedicalresearch.com</email>
    </contact>
    <investigator>
      <last_name>Robert Herring, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lovelace Scientific Resources</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78758</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherri Jones</last_name>
      <phone>512-901-8860</phone>
      <email>sjones@lrri.org</email>
    </contact>
    <investigator>
      <last_name>Alice Friedman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dynamed Clinical Research</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77034</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patty Gloyd</last_name>
      <phone>281-517-0550</phone>
      <phone_ext>204</phone_ext>
      <email>patty@dmclinicalresearch.com</email>
    </contact>
    <investigator>
      <last_name>Natarajan Bala, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Manassas Clinical Research</name>
      <address>
        <city>Manassas</city>
        <state>Virginia</state>
        <zip>20110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jyotsna Sandil</last_name>
      <phone>703-330-1112</phone>
      <email>jyotsnasandil@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Nabil Andrawis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Clinical Research</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Watson</last_name>
      <phone>757-461-3633</phone>
      <email>jwatson@ncinc.net</email>
    </contact>
    <investigator>
      <last_name>Barry C Lubin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wisconsin Center for Advanced Research</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Anderson, CMA,CCRC</last_name>
      <phone>414-908-6630</phone>
      <email>kathya@wigia.com</email>
    </contact>
    <investigator>
      <last_name>Daniel Geenen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 21, 2014</lastchanged_date>
  <firstreceived_date>December 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gastroparesis</keyword>
  <keyword>Diabetic</keyword>
  <keyword>Delayed gastric emptying</keyword>
  <keyword>Gastric stasis</keyword>
  <keyword>Nausea</keyword>
  <keyword>Vomiting</keyword>
  <keyword>Bloating</keyword>
  <keyword>Abdominal pain</keyword>
  <keyword>Early satiety</keyword>
  <keyword>Gastropathy</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gastroparesis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Metoclopramide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
